Want to see SSII full AI Analyst Report?
SSII Stock Chart & Stats
$6.42
$0.01(0.13%)
At close: 4:00 PM EST
$6.42
$0.01(0.13%)
Day’s Range― - ―
52-Week Range$3.11 - $10.00
Previous CloseN/A
Volume157.00
Average Volume (3M)63.38K
Market Cap
$695.46M
Enterprise Value$645.12M
Total Cash (Recent Filing)$15.98M
Total Debt (Recent Filing)$13.82M
Price to Earnings (P/E)―
Beta9.33
Next Earnings
Aug 06, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding200,131,530
10 Day Avg. Volume71,100
30 Day Avg. Volume63,382
Financial Highlights & Ratios
PEG Ratio2.12
Price to Book (P/B)28.24
Price to Sales (P/S)25.40
P/FCF Ratio-48.61
Enterprise Value/Market Cap0.93
Enterprise Value/Revenue13.32
Enterprise Value/Gross Profit27.52
Enterprise Value/Ebitda-174.01
Forecast
1Y Price Target
$7.00Price Target Upside9.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth & Margin ExpansionSustained top-line growth with improving gross margins signals better unit economics and operating leverage. Higher margins reduce the incremental cash needed per procedure, support scalable consumables and service revenue, and improve the structural path toward eventual profitability.
Clinical Adoption & Installed BaseA growing installed base and broad physician training create recurring consumable sales, service contracts and switching costs. Multi‑specialty use and thousands of completed procedures provide clinical validation and durable adoption that supports recurring revenue and competitive moat over time.
Conservative LeverageLow debt levels and a strengthening equity base preserve financial flexibility and reduce bankruptcy risk. Conservative leverage gives management time to scale operations and iterate products without immediate refinancing pressure, supporting sustainable investment in commercialization.
Bears Say
Negative Cash GenerationPersistent negative operating and free cash flow indicate the business consumes capital to grow. This materially increases reliance on external funding, compresses reinvestment capacity, and raises execution risk if capital markets tighten or fundraising becomes more dilutive.
Ongoing UnprofitabilityA sustained negative net margin means returns on incremental sales remain uncertain. Continued losses depress ROE and shareholder returns, require ongoing funding, and mean the business must translate revenue growth into structural operating profit to justify scale.
Reliance On Equity FinancingAn active $50M ATM and recent private placements show dependence on equity markets to fund growth. That reliance can dilute shareholders and creates execution risk if future raises are needed during weaker market windows or if pricing pressures limit access to non-dilutive financing.
SS Innovations International News
SSII FAQ
What was Ss Innovations International, Inc’s price range in the past 12 months?
Ss Innovations International, Inc lowest stock price was $3.11 and its highest was $10.00 in the past 12 months.
What is Ss Innovations International, Inc’s market cap?
Ss Innovations International, Inc’s market cap is $695.46M.
When is Ss Innovations International, Inc’s upcoming earnings report date?
Ss Innovations International, Inc’s upcoming earnings report date is Aug 06, 2026 which is in 12 days.
How were Ss Innovations International, Inc’s earnings last quarter?
Ss Innovations International, Inc released its earnings results on May 13, 2026. The company reported -$0.02 earnings per share for the quarter, the consensus estimate of -$0.02 by $0.
Is Ss Innovations International, Inc overvalued?
According to Wall Street analysts Ss Innovations International, Inc’s price is currently Undervalued.
Does Ss Innovations International, Inc pay dividends?
Ss Innovations International, Inc does not currently pay dividends.
What is Ss Innovations International, Inc’s EPS estimate?
Ss Innovations International, Inc’s EPS estimate is -0.01.
How many shares outstanding does Ss Innovations International, Inc have?
Ss Innovations International, Inc has 200,131,530 shares outstanding.
What happened to Ss Innovations International, Inc’s price movement after its last earnings report?
Ss Innovations International, Inc reported an EPS of -$0.02 in its last earnings report, expectations of -$0.02. Following the earnings report the stock price went down -2.92%.
Which hedge fund is a major shareholder of Ss Innovations International, Inc?
Currently, no hedge funds are holding shares in SSII
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SS Innovations International Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.00 (9.03% Upside)
$7.00 (9.03% Upside)
Blogger Sentiment
Bullish
SSII Sentiment 70%
Sector Average 65%
Sector Average 65%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.0%
Last 30 Days ▲ 3.0%
Last 30 Days ▲ 3.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-47.88%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
42.69%
Trailing 12-Months
Company Description
Ss Innovations International, Inc
SS Innovations International, Inc., situated in Fort Lauderdale, Florida, focuses on the development of sophisticated robotic systems for surgical use. Their offerings encompass the SSI Mantra, a specialized surgical robot, and SSI Mudra, a suite of surgical instruments designed to facilitate various operations, including robotic cardiac surgery. The company also provides SSI Maya, a dedicated platform for robotic surgical interventions, along with OMNI 3D HD, which delivers a real-time, high-definition 3D perspective of the surgical field within the operating room.
SSII Stock 12 Month Forecast
Average Price Target
$7.00
▲(9.03% Upside)
Technical Analysis
Conmed
―
Artivion
―
Integra Lifesciences
―
Tandem Diabetes Care
―
Establishment Labs Holdings
―
Ownership Overview
67.67% Insiders
0.46% Mutual Funds
0.16% Other Institutional Investors
31.60% Public Companies and
Individual Investors